Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of LVTX will rise by +5.95% over the next 2 Weeks and hit $1.84 by Thursday, December 4, 2025. In that time frame, LVTX's share price is expected to range between $1.79 and $1.89.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Dec 4, 2025 | 1.78 | 1.83 | 1.88 |
| Dec 3, 2025 | 1.78 | 1.83 | 1.88 |
| Dec 2, 2025 | 1.76 | 1.81 | 1.87 |
| Dec 1, 2025 | 1.74 | 1.79 | 1.84 |
| Nov 28, 2025 | 1.72 | 1.77 | 1.82 |
| Nov 27, 2025 | 1.73 | 1.78 | 1.83 |
| Nov 26, 2025 | 1.73 | 1.78 | 1.83 |
| Nov 25, 2025 | 1.72 | 1.77 | 1.81 |
| Nov 24, 2025 | 1.69 | 1.74 | 1.78 |
| Nov 21, 2025 | 1.67 | 1.72 | 1.77 |
LVTX shares fell -3.87% in Friday, November 28, 2025's trading session, dropping from a previous close of $1.74 to move at $1.74. The stock demonstrated notable intraday movement (see LVTX's key stats for a full breakdown), fluctuating between $1.74 and $1.74, a 0 trading range. While recent weeks have seen some volatility, LVTX has managed to secure a +8.07% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 285.52K shares changing hands, 43.19K fewer than the previous session. This amounted to $496.81K in total market activity.
Will LVTX Continue Its Upward Trend?
According to analyst ratings and projections for LVTX, LAVA Therapeutics N.V. shares are anticipated to increase by +7.56%, potentially reaching $1.88 per share by December 4, 2025. Short-term technical indicators currently suggest a neutral sentiment for LVTX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 7 positive trading days within the past 30 sessions. Based on the LVTX stock forecast, now is a good time to buy LVTX stock because its current trading price is -5.04% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on LVTX covering social and institutional perspectives.
LVTX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into LVTX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 61.67% to 62.52%) suggest the stock is in a bullish momentum phase. The 50-day RSI, at 58.31%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 54.07%, maintains a neutral outlook for the long term. Insights into LVTX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
LAVA Therapeutics N.V. Monthly Forecast 2025–2026
December 2025
According to our latest forecast models, LAVA Therapeutics N.V. (LVTX) is positioned to show a strong performance in December 2025. The price is predicted to move between $4.54 and $5.00, settling at an average of $4.78. This could translate to a +174.71% gain.
January 2026
Based on current market signals, LAVA Therapeutics N.V. is projected to trend january 2026. We forecast a trading range from $4.61 to $6.24, with a likely average price of $5.52. Investors could expect a potential return of +217.24%.
February 2026
Our predictive algorithms indicate LAVA Therapeutics N.V. stock may see a shift in February 2026. The expected range spans $4.15–$5.34, with an average target of $5.02. This represents a positive outlook and a possible gain of +188.51%.
March 2026
Analyzing established trends, LAVA Therapeutics N.V. looks set to move in March 2026. Projections place the stock between $4.07 and $7.23, averaging around $5.90. This suggests a +239.08% gain from current levels.
April 2026
Market indicators suggest LAVA Therapeutics N.V. could experience notable changes during April 2026. Prices could fluctuate within $3.94 to $6.82, with a midpoint forecast of $6.07. The stock might deliver a +248.85% gain.
May 2026
Forecasting for May 2026, models estimate that LAVA Therapeutics N.V. may undergo key fluctuations. If trends hold, the stock might trade between $3.46 and $7.85, averaging $6.94. This signals a positive trajectory with potential returns around +298.85%.
June 2026
According to our latest forecast models, LAVA Therapeutics N.V. (LVTX) is positioned to show a strong performance in June 2026. The price is predicted to move between $2.04 and $8.86, settling at an average of $7.32. This could translate to a +320.69% gain.
July 2026
Based on current market signals, LAVA Therapeutics N.V. is projected to trend july 2026. We forecast a trading range from $1.15 to $7.80, with a likely average price of $6.50. Investors could expect a potential return of +273.56%.
August 2026
Our predictive algorithms indicate LAVA Therapeutics N.V. stock may see a shift in August 2026. The expected range spans $0.33–$9.72, with an average target of $7.23. This represents a positive outlook and a possible gain of +315.52%.
September 2026
Analyzing established trends, LAVA Therapeutics N.V. looks set to move in September 2026. Projections place the stock between $0.00 and $9.91, averaging around $7.28. This suggests a +318.39% gain from current levels.
October 2026
Market indicators suggest LAVA Therapeutics N.V. could experience notable changes during October 2026. Prices could fluctuate within $0.00 to $12.09, with a midpoint forecast of $8.26. The stock might deliver a +374.71% gain.
November 2026
Forecasting for November 2026, models estimate that LAVA Therapeutics N.V. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $14.31, averaging $9.42. This signals a positive trajectory with potential returns around +441.38%.
LVTX's history of dividends and stock splits also plays a role in long-term investor confidence.

